Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Depreciation and Depletion (2018 - 2023)

Viemed Healthcare filings provide 6 years of Depreciation and Depletion readings, the most recent being $6.0 million for Q3 2023.

  • On a quarterly basis, Depreciation and Depletion rose 44.99% to $6.0 million in Q3 2023 year-over-year; TTM through Sep 2023 was $20.3 million, a 41.31% increase, with the full-year FY2022 number at $15.6 million, up 38.17% from a year prior.
  • Depreciation and Depletion hit $6.0 million in Q3 2023 for Viemed Healthcare, up from $5.2 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $6.0 million in Q3 2023 to a low of $1.3 million in Q2 2019.
  • Median Depreciation and Depletion over the past 5 years was $2.8 million (2020), compared with a mean of $3.1 million.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 70.68% in 2019 and later increased 9.98% in 2021.
  • Viemed Healthcare's Depreciation and Depletion stood at $2.0 million in 2019, then soared by 41.71% to $2.8 million in 2020, then increased by 9.98% to $3.1 million in 2021, then soared by 40.16% to $4.4 million in 2022, then soared by 36.63% to $6.0 million in 2023.
  • The last three reported values for Depreciation and Depletion were $6.0 million (Q3 2023), $5.2 million (Q2 2023), and $4.8 million (Q1 2023) per Business Quant data.